On December 13, 2024, Rachel K. King, an insider at Novavax, executed a significant stock transaction. King sold 4,150 shares of Novavax common stock in an open market sale at an average price of $9.0205 per share.The total value of the disposed shares amounted to approximately $37,435. Following this transaction, King's direct ownership in Novavax decreased to 14,770 shares. The sale was reported as completed, indicating that all planned transactions have been executed.This insider sale may be of interest to investors monitoring executive trading patterns at Novavax. However, it's important to note that individual transactions don't necessarily indicate broader company trends and should be considered alongside other financial and market information.

On December 13, 2024, Rachel K. King, an insider at Novavax, executed a significant stock transaction. King sold 4,150 shares of Novavax common stock in an open market sale at an average price of $9.0205 per share.The total value of the disposed shares amounted to approximately $37,435. Following this transaction, King's direct ownership in Novavax decreased to 14,770 shares. The sale was reported as completed, indicating that all planned transactions have been executed.This insider sale may be of interest to investors monitoring executive trading patterns at Novavax. However, it's important to note that individual transactions don't necessarily indicate broader company trends and should be considered alongside other financial and market information.